Ramipril/amlodipin Pliva 5 mg/5 mg tvrde kapsule
| Name | Ramipril/amlodipin Pliva 5 mg/5 mg tvrde kapsule |
|---|---|
| Marketing Authorisation Number | HR-H-023212604 |
| Active Substance | ramipril amlodipinbesilat |
| Composition | jedna kapsula sadrži 5 mg ramiprila i 5 mg amlodipina (u obliku amlodipinbesilata) |
| Pharmaceutical Form | kapsula, tvrda |
| Manufacturer | Adamed Pharma S.A., Pabianice, Poljska Adamed Pharma S.A., Ksawerow, Poljska Teva Operations Poland Sp. z o.o., Krakow, Poljska Merckle GmbH, Blaubeuren, Baden-Wuerttemberg, Njemačka |
| Marketing Authorisation Holder | Pliva Hrvatska d.o.o., Prilaz baruna Filipovića 25, Zagreb, Hrvatska |
| Marketing Authorisation Date | 10.05.2022 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/21-02/99 |
| Registration Number | 381-12-01/154-22-03 |
| Prescription | Medicinal product subject to medical prescription |
| Type of prescription | Medicinal product on medical prescription for renewable delivery |
| Distribution | Supply through pharmacies (community) |
| Advertising to general public | not allowed |
| ATC Code | C09BB07 |
| Marketing status | Never marketed |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
